Todd Wider Sells 50,000 Shares of ASP Isotopes (NASDAQ:ASPI) Stock

ASP Isotopes Inc. (NASDAQ:ASPI) Director Todd Wider sold 50,000 shares of the firm’s stock in a transaction dated Monday, June 29th. The shares were sold at an average price of $6.25, for a total transaction of $312,500.00. Following the completion of the transaction, the director directly owned 722,247 shares in the company, valued at $4,514,043.75. This trade represents a 6.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

ASP Isotopes Trading Down 0.8%

NASDAQ ASPI traded down $0.05 during trading hours on Wednesday, hitting $6.17. The company’s stock had a trading volume of 3,923,284 shares, compared to its average volume of 4,990,399. ASP Isotopes Inc. has a twelve month low of $3.92 and a twelve month high of $14.49. The firm has a market capitalization of $776.80 million, a P/E ratio of -2.97 and a beta of 3.51. The stock has a fifty day moving average of $6.24 and a 200 day moving average of $5.90. The company has a quick ratio of 4.37, a current ratio of 4.39 and a debt-to-equity ratio of 0.69.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings results on Wednesday, May 20th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.28) by $0.06. The business had revenue of $8.36 million for the quarter, compared to the consensus estimate of $3.68 million. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%.

Institutional Trading of ASP Isotopes

Several large investors have recently modified their holdings of the stock. Mercer Global Advisors Inc. ADV boosted its stake in ASP Isotopes by 8.3% during the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 21,056 shares of the company’s stock valued at $203,000 after purchasing an additional 1,622 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in ASP Isotopes by 9.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,840 shares of the company’s stock valued at $153,000 after buying an additional 1,878 shares during the last quarter. Legal & General Group Plc boosted its holdings in ASP Isotopes by 30.4% during the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock worth $81,000 after acquiring an additional 1,953 shares during the last quarter. BNP Paribas Financial Markets grew its stake in shares of ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after acquiring an additional 2,548 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of ASP Isotopes by 9.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company’s stock valued at $148,000 after purchasing an additional 2,709 shares during the last quarter. Institutional investors and hedge funds own 16.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ASPI. Canaccord Genuity Group reissued a “buy” rating and issued a $11.00 price objective on shares of ASP Isotopes in a research note on Tuesday, April 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.